2 Einträge |
Seite 1 / 1
![]() |
Early clinical outcomes as a function of use of newer oral P2Y12 inhibitors versus clopidogrel in the EUROMAX trial. |
Huber K, Ducrocq G, Hamm CW, van 't Hof A, Lapostolle F, Coste P, Gordini G, Steinmetz J, Verheugt FWA, Adgey J, Nibbe L, Kaniĉ V, Clemmensen P, Zeymer U, Bernstein D, Prats J, Deliargyris EN, Gabriel Steg P |
Open heart. 2017 Nov 28. doi: 10.1136/openhrt-2017-000677. pii: openhrt-2017-000677. pmc: PMC5708315 |
PMID: 29225903 |
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study. |
Coleman RL, Lorusso D, Gennigens C, González-Martín A, Randall L, Cibula D, Lund B, Woelber L, Pignata S, Forget F, Redondo A, Vindeløv SD, Chen M, Harris JR, Smith M, Nicacio LV, Teng MSL, Laenen A, Rangwala R, Manso L, Mirza M, Monk BJ, Vergote I |
The Lancet. Oncology. 2021 Apr 9. pii: S1470-2045(21)00056-5. doi: 10.1016/S1470-2045(21)00056-5 |
PMID: 33845034 |
2 Einträge |
Seite 1 / 1
![]() |